Basal insulin has a "neutral effect" on cardiovascular events
Overbeck, P.
MMW Fortschritte der Medizin 154(12): 24
2012
ISSN/ISBN: 1438-3276 PMID: 22880290 Document Number: 660578
Document emailed within 1 workday
Related Documents
Lepore, G.; Dodesini, A.R.; Nosari, I.; Trevisan, R. 2004: Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study Diabetes Nutrition and Metabolism 17(2): 84-89Dobrohorska, H.; Sulima, D.; Oskaldowicz, K.; Gruszczyńska, M.; Gołebiowska, I. 1981: Effect of refeeding after starvation on basal and tolbutamide-stimulated insulin secretion and beta-adrenergic receptor function in the regulation of insulin release and lipolysis in obese patients Acta Physiologica Polonica 32(6): 703-712
Ametov, A.S.; Kochergina, I.I.; Ulanova, K.A. 2010: Effect of insulin therapy on insulin resistance and risk for ischemic heart disease and death from cardiovascular pathology in patients with diabetes mellitus, type 2 Terapevticheskii Arkhiv 82(3): 42-46
Champeyroux, J.; Moinade, S.; Gaillard, G.; Boucher, D. 1978: Blood prolactin in insulin-dependent diabetics. Basal study and effect of stimulation La Nouvelle Presse Medicale 7(12): 1007-1008
Nossent, H. 2000: Risk of cardiovascular events and effect on mortality in patients with rheumatoid arthritis Journal of Rheumatology 27(9): 2282-2283
Gasić, S.; Bratusch-Marrain, P.; Waldhäusl, W.; Korn, A. 1988: Effect of verapamil on basal and glucagon-dependent splanchnic glucose metabolism and insulin secretion in man International Journal of Clinical Pharmacology Therapy and Toxicology 26(1): 36-40
Vartan'ian, G.V. 1973: Effect of atropine on the basal and insulin-stimulated gastric secretion in patients with peptic ulcer Terapevticheskii Arkhiv 45(8): 104-107
Potter, D.E.; Morris, J.W. 1980: Effect of ethanol on basal and arginine-stimulated plasma levels of glucose, insulin and glucagon in fasted unanesthetized rabbits Archives Internationales de Pharmacodynamie et de Therapie 246(2): 180-186
Chen, Y.; Wang, J.; An, Y.; Gong, Q.; He, Y.; Zhang, B.; Li, H.; Shuai, Y.; Tang, X.; Jiang, Y.; Hong, J.; Yang, W.; Hu, Y.; Li, G. 2015: Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study Zhonghua Nei Ke Za Zhi 54(1): 13-17
Dirksen, E.R. 1982: Ciliary basal body morphogenesis: the early events Symposia of the Society for Experimental Biology 35: 439-463
Bu, S.; Guo, X.-H.; Yang, W.-Y.; Lu, G.-Z.; Yang, Z.-J.; Ren, T.-T.; Gao, Y. 2007: Post-hoc analyses of type 2 diabetes patients switch from premixed insulin regimen to basal insulin plus oral hypoglycemic agents regimen Zhonghua Yi Xue Za Zhi 87(44): 3115-3118
Fellah, H.; Feki, M.; Feki, H.; Souissi, M.; Kaabachi, N.; Abdallah, T.B.; Massy, Z.A.; Maiz, H.B.; Lacour, B.; Mebazaa, A. 2004: Classical and "Non-classical" Cardiovascular Risk Factors in Tunisian Patients with End Stage Renal Disease: Prevalence and Association with Cardiovascular Events Clinical Laboratory 50(7-8): 447-453
Fang, F.-s.; Tian, H.; Li, C.-l.; Yan, S.-t.; Miao, X.-y.; Cheng, X.-l. 2011: Comparison of postprandial insulin and fasting insulin on the evaluation of cardiovascular risk factors Zhonghua Yi Xue Za Zhi 91(14): 946-949
Hinghofer-Szalkay, H.; Loder, I.; Rossler, A.; Jezova, D. 2002: 'Neutral point titration': cardiovascular regulation during combined (LBNP/HDT vs. LBPP/HUT) stimulation Journal of Gravitational Physiology: a Journal of the International Society for Gravitational Physiology 9(1): P93-P94
Cannella, G.; Picotti, G.B.; Giambelli, A.; Scolari, F.; Cesura, A.M.; Tosoni, S.; Maiorca, R. 1982: Effect of pretreatment with atenolol and propranolol on sympatho-adrenal and cardiovascular responses to acute insulin-induced hypoglycaemia in the hypertensive patient Giornale Italiano di Cardiologia 12(12): 884-888
García, Félix.Miguel.; García Ortiz, A.; Montero Alonso, Mía.José. 2006: Reducing cardiovascular risk in a table is not equivalent to reducing cardiovascular events Atencion Primaria 38(7): 417; Author Reply 417-8
Armstrong, J.D.; Stanko, R.L.; Cohick, W.S.; Simpson, R.B.; Harvey, R.W.; Huff, B.G.; Clemmons, D.R.; Whitacre, M.D.; Campbell, R.M.; Heimer, E.P. 1992: Endocrine events prior to puberty in heifers: role of somatotropin, insulin-like growth factor-I and insulin-like growth factor binding proteins Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 43(4 Suppl. 1): 179-193
Rausch, R. 2015: Basal insulin and liraglutide combined in a pen Medizinische Monatsschrift für Pharmazeuten 38(4): 154-156
Hiatt, W.R. 2008: Aspirin for prevention of cardiovascular events Bmj 337: A1806
Gortner, S.R.; Jenkins, L.S. 1990: Recovery after cardiovascular events. Overview Heart and Lung: the Journal of Critical Care 19(5 Pt 1): 471-473